BioScrip to fully repay credit agreement debts with new note proceeds

By Tali Rackner

Minneapolis, June 29 – BioScrip, Inc. plans to repay all amounts outstanding under its existing credit agreements using the proceeds from sales of first- and second-lien notes, according to an 8-K filing with the Securities and Exchange Commission.

Specifically, the company will fully repay the amounts outstanding under its credit agreement dated July 31, 2013 with SunTrust Bank, Jefferies Finance LLC and Morgan Stanley Senior Funding, Inc., and its priming credit agreement dated Jan. 6, 2017 with SunTrust Bank as administrative agent.

Both credit agreements will subsequently be terminated.

BioScrip intends to use the remaining proceeds for working capital and general corporate purposes.

BioScrip is a Denver-based provider of infusion and home care management solution

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.